Health & Personal Care
HIGH
FDA DRUG
Carbamazepine Extended-Release 400 mg Tablets Recalled for Failed Dissolution Specifications (D-0675
FDA recalls Carbamazepine Extended-Release Tablets, 400 mg, distributed nationwide by American Health Packaging. The recall cites failed dissolution specifications and class II classification. Consumers should stop using and contact healthcare providers for guidance.
Carbamazepine
Failed Dissolution